HEADER PROTEIN BINDING 22-NOV-15 5EWX
TITLE FUSION PROTEIN OF T4 LYSOZYME AND B4 DOMAIN OF PROTEIN A FROM
TITLE 2 STAPHYLOCOCCAL AUREUS WITH CHEMICAL CROSS-LINKER EY-CBS
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: ENDOLYSIN,IMMUNOGLOBULIN G-BINDING PROTEIN A,ENDOLYSIN;
COMPND 3 CHAIN: A, B;
COMPND 4 FRAGMENT: UNP RESIDUES 1-35, 219-266, 38-164;
COMPND 5 SYNONYM: LYSIS PROTEIN,LYSOZYME,MURAMIDASE,IGG-BINDING PROTEIN A,
COMPND 6 STAPHYLOCOCCAL PROTEIN A;
COMPND 7 EC: 3.2.1.17;
COMPND 8 ENGINEERED: YES;
COMPND 9 MUTATION: YES;
COMPND 10 OTHER_DETAILS: THE FUSION PROTEIN OF T4 LYSOZYME (RESIDUES 1-35),
COMPND 11 LINKER GGGGSGGGGS, PROTEIN A (B4 DOMAIN, RESIDUES 212-266), AND T4
COMPND 12 LYSOZYME (RESIDUES 38-164)
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: ENTEROBACTERIA PHAGE T4, STAPHYLOCOCCUS AUREUS;
SOURCE 3 ORGANISM_TAXID: 10665, 1280;
SOURCE 4 GENE: SPA;
SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI;
SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562
KEYWDS FUSION, EY-CBS, ALPHA HELIX, CROSS-LINKER, PROTEIN BINDING
EXPDTA X-RAY DIFFRACTION
AUTHOR W.H.JEONG,H.LEE,D.H.SONG,J.O.LEE
REVDAT 2 08-NOV-23 5EWX 1 REMARK
REVDAT 1 30-MAR-16 5EWX 0
JRNL AUTH W.H.JEONG,H.LEE,D.H.SONG,J.H.EOM,S.C.KIM,H.S.LEE,H.LEE,
JRNL AUTH 2 J.O.LEE
JRNL TITL CONNECTING TWO PROTEINS USING A FUSION ALPHA HELIX
JRNL TITL 2 STABILIZED BY A CHEMICAL CROSS LINKER.
JRNL REF NAT COMMUN V. 7 11031 2016
JRNL REFN ESSN 2041-1723
JRNL PMID 26980593
JRNL DOI 10.1038/NCOMMS11031
REMARK 2
REMARK 2 RESOLUTION. 2.60 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : PHENIX 1.9_1692
REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN
REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE,
REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER,
REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY,
REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON,
REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI,
REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT
REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART
REMARK 3
REMARK 3 REFINEMENT TARGET : ML
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.60
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 42.75
REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.390
REMARK 3 COMPLETENESS FOR RANGE (%) : 94.1
REMARK 3 NUMBER OF REFLECTIONS : 35397
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 R VALUE (WORKING + TEST SET) : 0.208
REMARK 3 R VALUE (WORKING SET) : 0.203
REMARK 3 FREE R VALUE : 0.253
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 9.990
REMARK 3 FREE R VALUE TEST SET COUNT : 3535
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS).
REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE
REMARK 3 1 42.7507 - 7.5890 0.92 1255 137 0.1762 0.2246
REMARK 3 2 7.5890 - 6.0290 0.97 1325 148 0.1903 0.1909
REMARK 3 3 6.0290 - 5.2685 0.97 1296 147 0.1911 0.2207
REMARK 3 4 5.2685 - 4.7875 0.97 1335 145 0.1636 0.2181
REMARK 3 5 4.7875 - 4.4447 0.96 1279 138 0.1483 0.2280
REMARK 3 6 4.4447 - 4.1829 0.96 1321 148 0.1562 0.2035
REMARK 3 7 4.1829 - 3.9736 0.96 1282 138 0.1534 0.1887
REMARK 3 8 3.9736 - 3.8007 0.95 1256 139 0.1594 0.2425
REMARK 3 9 3.8007 - 3.6545 0.96 1338 146 0.1693 0.2136
REMARK 3 10 3.6545 - 3.5284 0.95 1281 144 0.1858 0.2234
REMARK 3 11 3.5284 - 3.4182 0.94 1295 142 0.1920 0.2458
REMARK 3 12 3.4182 - 3.3205 0.95 1221 141 0.2122 0.2687
REMARK 3 13 3.3205 - 3.2331 0.94 1330 147 0.2438 0.3131
REMARK 3 14 3.2331 - 3.1543 0.95 1279 147 0.2452 0.2828
REMARK 3 15 3.1543 - 3.0826 0.95 1270 143 0.2794 0.3430
REMARK 3 16 3.0826 - 3.0170 0.94 1276 143 0.2721 0.3322
REMARK 3 17 3.0170 - 2.9567 0.94 1251 137 0.2657 0.3383
REMARK 3 18 2.9567 - 2.9009 0.94 1262 140 0.2631 0.3173
REMARK 3 19 2.9009 - 2.8491 0.94 1314 149 0.2519 0.3351
REMARK 3 20 2.8491 - 2.8008 0.94 1210 133 0.2568 0.3592
REMARK 3 21 2.8008 - 2.7556 0.93 1299 145 0.2864 0.3336
REMARK 3 22 2.7556 - 2.7132 0.94 1242 140 0.3063 0.3154
REMARK 3 23 2.7132 - 2.6733 0.93 1298 139 0.3058 0.3504
REMARK 3 24 2.6733 - 2.6357 0.92 1180 127 0.3074 0.3809
REMARK 3 25 2.6357 - 2.6001 0.82 1167 132 0.3223 0.3652
REMARK 3
REMARK 3 BULK SOLVENT MODELLING.
REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL
REMARK 3 SOLVENT RADIUS : 1.11
REMARK 3 SHRINKAGE RADIUS : 0.90
REMARK 3 K_SOL : NULL
REMARK 3 B_SOL : NULL
REMARK 3
REMARK 3 ERROR ESTIMATES.
REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.390
REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 31.460
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : NULL
REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : NULL
REMARK 3 B22 (A**2) : NULL
REMARK 3 B33 (A**2) : NULL
REMARK 3 B12 (A**2) : NULL
REMARK 3 B13 (A**2) : NULL
REMARK 3 B23 (A**2) : NULL
REMARK 3
REMARK 3 TWINNING INFORMATION.
REMARK 3 FRACTION: NULL
REMARK 3 OPERATOR: NULL
REMARK 3
REMARK 3 DEVIATIONS FROM IDEAL VALUES.
REMARK 3 RMSD COUNT
REMARK 3 BOND : 0.010 3458
REMARK 3 ANGLE : 1.493 4670
REMARK 3 CHIRALITY : 0.056 508
REMARK 3 PLANARITY : 0.011 608
REMARK 3 DIHEDRAL : 15.900 1306
REMARK 3
REMARK 3 TLS DETAILS
REMARK 3 NUMBER OF TLS GROUPS : 2
REMARK 3 TLS GROUP : 1
REMARK 3 SELECTION: CHAIN A
REMARK 3 ORIGIN FOR THE GROUP (A): 91.2027 11.6323 156.7791
REMARK 3 T TENSOR
REMARK 3 T11: 0.5518 T22: 0.3477
REMARK 3 T33: 0.3177 T12: -0.0215
REMARK 3 T13: 0.1165 T23: -0.0115
REMARK 3 L TENSOR
REMARK 3 L11: 1.2733 L22: 3.6944
REMARK 3 L33: 1.9190 L12: -1.0395
REMARK 3 L13: 0.8182 L23: -1.3185
REMARK 3 S TENSOR
REMARK 3 S11: -0.0625 S12: -0.2305 S13: 0.2068
REMARK 3 S21: -0.0653 S22: 0.1484 S23: 0.1493
REMARK 3 S31: -0.2039 S32: -0.0624 S33: -0.0783
REMARK 3 TLS GROUP : 2
REMARK 3 SELECTION: CHAIN B
REMARK 3 ORIGIN FOR THE GROUP (A): 115.0724 -20.1956 140.0066
REMARK 3 T TENSOR
REMARK 3 T11: 0.4461 T22: 0.3367
REMARK 3 T33: 0.2298 T12: -0.0154
REMARK 3 T13: 0.0730 T23: -0.0096
REMARK 3 L TENSOR
REMARK 3 L11: 2.5640 L22: 2.2658
REMARK 3 L33: 0.8980 L12: -1.4214
REMARK 3 L13: 0.1549 L23: -0.3682
REMARK 3 S TENSOR
REMARK 3 S11: 0.0618 S12: -0.0492 S13: -0.0371
REMARK 3 S21: 0.0510 S22: 0.0554 S23: 0.0240
REMARK 3 S31: 0.1479 S32: -0.1756 S33: -0.1081
REMARK 3
REMARK 3 NCS DETAILS
REMARK 3 NUMBER OF NCS GROUPS : NULL
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4
REMARK 4 5EWX COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 24-NOV-15.
REMARK 100 THE DEPOSITION ID IS D_1000215630.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 08-OCT-15
REMARK 200 TEMPERATURE (KELVIN) : 77
REMARK 200 PH : 7.5
REMARK 200 NUMBER OF CRYSTALS USED : NULL
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : Y
REMARK 200 RADIATION SOURCE : PAL/PLS
REMARK 200 BEAMLINE : 7A (6B, 6C1)
REMARK 200 X-RAY GENERATOR MODEL : NULL
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 0.97940
REMARK 200 MONOCHROMATOR : NULL
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : CCD
REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL
REMARK 200 DATA SCALING SOFTWARE : SCALEPACK
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 35397
REMARK 200 RESOLUTION RANGE HIGH (A) : 2.600
REMARK 200 RESOLUTION RANGE LOW (A) : 50.000
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 99.1
REMARK 200 DATA REDUNDANCY : 3.500
REMARK 200 R MERGE (I) : NULL
REMARK 200 R SYM (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 18.3000
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL
REMARK 200 COMPLETENESS FOR SHELL (%) : NULL
REMARK 200 DATA REDUNDANCY IN SHELL : NULL
REMARK 200 R MERGE FOR SHELL (I) : NULL
REMARK 200 R SYM FOR SHELL (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT
REMARK 200 SOFTWARE USED: PHASER
REMARK 200 STARTING MODEL: 1LYD, 1DEE
REMARK 200
REMARK 200 REMARK: THE ENTRY CONTAINS FRIEDEL PAIRS IN I_PLUS/MINUS COLUMNS.
REMARK 200 SQUARE ROD-PLATE
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 61.97
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.23
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: 1.84M NA/K PHOSPHATE, PH 7.5,
REMARK 280 EVAPORATION, TEMPERATURE 277K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X,Y,-Z
REMARK 290 3555 X+1/2,Y+1/2,Z
REMARK 290 4555 -X+1/2,Y+1/2,-Z
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000
REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 44.76100
REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 74.92500
REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 44.76100
REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 74.92500
REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1, 2
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 350
REMARK 350 BIOMOLECULE: 2
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 APPLY THE FOLLOWING TO CHAINS: B
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 GLY A 1209
REMARK 465 GLY A 1210
REMARK 465 GLY A 1211
REMARK 465 GLY A 1212
REMARK 465 SER A 1213
REMARK 465 GLY A 1214
REMARK 465 GLY A 1215
REMARK 465 GLY A 1216
REMARK 465 GLY A 1217
REMARK 465 SER A 1218
REMARK 465 VAL A 1218A
REMARK 465 ASP A 1218B
REMARK 465 ASN A 1218C
REMARK 465 LYS A 1218D
REMARK 465 PHE A 1218E
REMARK 465 ASN A 1218F
REMARK 465 LYS A 1218G
REMARK 465 SER B 1213
REMARK 465 GLY B 1214
REMARK 465 GLY B 1215
REMARK 465 GLY B 1216
REMARK 465 GLY B 1217
REMARK 465 SER B 1218
REMARK 465 VAL B 1218A
REMARK 465 ASP B 1218B
REMARK 465 ASN B 1218C
REMARK 465 LYS B 1218D
REMARK 465 PHE B 1218E
REMARK 465 ASN B 1218F
REMARK 465 LYS B 1218G
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT
REMARK 500
REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT.
REMARK 500
REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE
REMARK 500 O HOH B 1423 O HOH B 1428 1.61
REMARK 500 NE ARG A 154 O HOH A 1401 1.81
REMARK 500 NH1 ARG B 76 O HOH B 1401 1.82
REMARK 500 NH1 ARG A 76 O HOH A 1402 1.83
REMARK 500 OE2 GLU A 64 O HOH A 1403 1.84
REMARK 500 OE1 GLN B 1221 O HOH B 1402 1.87
REMARK 500 OG1 THR B 115 O HOH B 1403 1.90
REMARK 500 NE2 GLN B 1221 O HOH B 1404 1.98
REMARK 500 OH TYR A 139 O HOH A 1404 2.01
REMARK 500 N MET A 1 O HOH A 1405 2.01
REMARK 500 N GLU B 1219 O HOH B 1402 2.07
REMARK 500 O HOH B 1415 O HOH B 1433 2.07
REMARK 500 OE1 GLN B 1221 O HOH B 1404 2.08
REMARK 500 SG CYS A 40 O18 EYC A 1301 2.12
REMARK 500 O LYS A 65 O HOH A 1406 2.13
REMARK 500 OE1 GLN B 105 O HOH B 1405 2.14
REMARK 500 SG CYS A 40 C19 EYC A 1301 2.15
REMARK 500 O HOH B 1418 O HOH B 1435 2.16
REMARK 500 O HOH B 1432 O HOH B 1434 2.19
REMARK 500 O THR A 157 O HOH A 1407 2.19
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: CLOSE CONTACTS
REMARK 500
REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC
REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15
REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A
REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375
REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE
REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS.
REMARK 500
REMARK 500 DISTANCE CUTOFF:
REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS
REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS
REMARK 500
REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE
REMARK 500 O HOH A 1421 O HOH B 1417 1556 1.73
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 LEU A 33 -68.41 -100.72
REMARK 500 ASP A1248 89.93 -153.86
REMARK 500 GLN A1251 32.65 -79.79
REMARK 500 MET A 106 -4.38 -142.71
REMARK 500 LYS A 124 18.48 58.95
REMARK 500 ASP B1248 89.97 -151.99
REMARK 500 GLN B1251 23.37 -79.86
REMARK 500 MET B 106 -5.95 -143.07
REMARK 500 LYS B 124 19.84 59.28
REMARK 500
REMARK 500 REMARK: NULL
REMARK 610
REMARK 610 MISSING HETEROATOM
REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER;
REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER;
REMARK 610 I=INSERTION CODE):
REMARK 610 M RES C SSEQI
REMARK 610 EYC A 1301
REMARK 610 EYC B 1301
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue EYC A 1301
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC2
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue EYC B 1301
REMARK 999
REMARK 999 SEQUENCE
REMARK 999 THE AUTHOR STATES THAT THERE ARE ERRORS AT THESE POSITIONS IN THE
REMARK 999 SEQUENCE DATABASE
DBREF 5EWX A 1 35 UNP P00720 ENLYS_BPT4 1 35
DBREF 5EWX A 1218A 1266 UNP P38507 SPA_STAAU 212 266
DBREF 5EWX A 38 164 UNP P00720 ENLYS_BPT4 38 164
DBREF 5EWX B 1 35 UNP P00720 ENLYS_BPT4 1 35
DBREF 5EWX B 1218A 1266 UNP P38507 SPA_STAAU 212 266
DBREF 5EWX B 38 164 UNP P00720 ENLYS_BPT4 38 164
SEQADV 5EWX GLY A 12 UNP P00720 ARG 12 SEE SEQUENCE DETAILS
SEQADV 5EWX GLY A 1209 UNP P00720 LINKER
SEQADV 5EWX GLY A 1210 UNP P00720 LINKER
SEQADV 5EWX GLY A 1211 UNP P00720 LINKER
SEQADV 5EWX GLY A 1212 UNP P00720 LINKER
SEQADV 5EWX SER A 1213 UNP P00720 LINKER
SEQADV 5EWX GLY A 1214 UNP P00720 LINKER
SEQADV 5EWX GLY A 1215 UNP P00720 LINKER
SEQADV 5EWX GLY A 1216 UNP P00720 LINKER
SEQADV 5EWX GLY A 1217 UNP P00720 LINKER
SEQADV 5EWX SER A 1218 UNP P00720 LINKER
SEQADV 5EWX VAL A 1218A UNP P38507 ALA 212 ENGINEERED MUTATION
SEQADV 5EWX ALA A 1240 UNP P38507 GLY 240 ENGINEERED MUTATION
SEQADV 5EWX CYS A 1258 UNP P38507 GLU 258 ENGINEERED MUTATION
SEQADV 5EWX ALA A 1261 UNP P38507 LYS 261 ENGINEERED MUTATION
SEQADV 5EWX ALA A 1262 UNP P38507 LEU 262 ENGINEERED MUTATION
SEQADV 5EWX CYS A 40 UNP P00720 ASN 40 ENGINEERED MUTATION
SEQADV 5EWX THR A 54 UNP P00720 CYS 54 ENGINEERED MUTATION
SEQADV 5EWX ALA A 97 UNP P00720 CYS 97 ENGINEERED MUTATION
SEQADV 5EWX ARG A 137 UNP P00720 ILE 137 SEE SEQUENCE DETAILS
SEQADV 5EWX ALA A 162 UNP P00720 LYS 162 ENGINEERED MUTATION
SEQADV 5EWX GLY B 12 UNP P00720 ARG 12 SEE SEQUENCE DETAILS
SEQADV 5EWX GLY B 1209 UNP P00720 LINKER
SEQADV 5EWX GLY B 1210 UNP P00720 LINKER
SEQADV 5EWX GLY B 1211 UNP P00720 LINKER
SEQADV 5EWX GLY B 1212 UNP P00720 LINKER
SEQADV 5EWX SER B 1213 UNP P00720 LINKER
SEQADV 5EWX GLY B 1214 UNP P00720 LINKER
SEQADV 5EWX GLY B 1215 UNP P00720 LINKER
SEQADV 5EWX GLY B 1216 UNP P00720 LINKER
SEQADV 5EWX GLY B 1217 UNP P00720 LINKER
SEQADV 5EWX SER B 1218 UNP P00720 LINKER
SEQADV 5EWX VAL B 1218A UNP P38507 ALA 212 ENGINEERED MUTATION
SEQADV 5EWX ALA B 1240 UNP P38507 GLY 240 ENGINEERED MUTATION
SEQADV 5EWX CYS B 1258 UNP P38507 GLU 258 ENGINEERED MUTATION
SEQADV 5EWX ALA B 1261 UNP P38507 LYS 261 ENGINEERED MUTATION
SEQADV 5EWX ALA B 1262 UNP P38507 LEU 262 ENGINEERED MUTATION
SEQADV 5EWX CYS B 40 UNP P00720 ASN 40 ENGINEERED MUTATION
SEQADV 5EWX THR B 54 UNP P00720 CYS 54 ENGINEERED MUTATION
SEQADV 5EWX ALA B 97 UNP P00720 CYS 97 ENGINEERED MUTATION
SEQADV 5EWX ARG B 137 UNP P00720 ILE 137 SEE SEQUENCE DETAILS
SEQADV 5EWX ALA B 162 UNP P00720 LYS 162 ENGINEERED MUTATION
SEQRES 1 A 227 MET ASN ILE PHE GLU MET LEU ARG ILE ASP GLU GLY LEU
SEQRES 2 A 227 ARG LEU LYS ILE TYR LYS ASP THR GLU GLY TYR TYR THR
SEQRES 3 A 227 ILE GLY ILE GLY HIS LEU LEU THR LYS GLY GLY GLY GLY
SEQRES 4 A 227 SER GLY GLY GLY GLY SER VAL ASP ASN LYS PHE ASN LYS
SEQRES 5 A 227 GLU GLN GLN ASN ALA PHE TYR GLU ILE LEU HIS LEU PRO
SEQRES 6 A 227 ASN LEU ASN GLU GLU GLN ARG ASN ALA PHE ILE GLN SER
SEQRES 7 A 227 LEU LYS ASP ASP PRO SER GLN SER ALA ASN LEU LEU ALA
SEQRES 8 A 227 CYS ALA LYS ALA ALA ASN ASP ALA GLN SER LEU CYS ALA
SEQRES 9 A 227 ALA LYS SER GLU LEU ASP LYS ALA ILE GLY ARG ASN THR
SEQRES 10 A 227 ASN GLY VAL ILE THR LYS ASP GLU ALA GLU LYS LEU PHE
SEQRES 11 A 227 ASN GLN ASP VAL ASP ALA ALA VAL ARG GLY ILE LEU ARG
SEQRES 12 A 227 ASN ALA LYS LEU LYS PRO VAL TYR ASP SER LEU ASP ALA
SEQRES 13 A 227 VAL ARG ARG ALA ALA LEU ILE ASN MET VAL PHE GLN MET
SEQRES 14 A 227 GLY GLU THR GLY VAL ALA GLY PHE THR ASN SER LEU ARG
SEQRES 15 A 227 MET LEU GLN GLN LYS ARG TRP ASP GLU ALA ALA VAL ASN
SEQRES 16 A 227 LEU ALA LYS SER ARG TRP TYR ASN GLN THR PRO ASN ARG
SEQRES 17 A 227 ALA LYS ARG VAL ILE THR THR PHE ARG THR GLY THR TRP
SEQRES 18 A 227 ASP ALA TYR ALA ASN LEU
SEQRES 1 B 227 MET ASN ILE PHE GLU MET LEU ARG ILE ASP GLU GLY LEU
SEQRES 2 B 227 ARG LEU LYS ILE TYR LYS ASP THR GLU GLY TYR TYR THR
SEQRES 3 B 227 ILE GLY ILE GLY HIS LEU LEU THR LYS GLY GLY GLY GLY
SEQRES 4 B 227 SER GLY GLY GLY GLY SER VAL ASP ASN LYS PHE ASN LYS
SEQRES 5 B 227 GLU GLN GLN ASN ALA PHE TYR GLU ILE LEU HIS LEU PRO
SEQRES 6 B 227 ASN LEU ASN GLU GLU GLN ARG ASN ALA PHE ILE GLN SER
SEQRES 7 B 227 LEU LYS ASP ASP PRO SER GLN SER ALA ASN LEU LEU ALA
SEQRES 8 B 227 CYS ALA LYS ALA ALA ASN ASP ALA GLN SER LEU CYS ALA
SEQRES 9 B 227 ALA LYS SER GLU LEU ASP LYS ALA ILE GLY ARG ASN THR
SEQRES 10 B 227 ASN GLY VAL ILE THR LYS ASP GLU ALA GLU LYS LEU PHE
SEQRES 11 B 227 ASN GLN ASP VAL ASP ALA ALA VAL ARG GLY ILE LEU ARG
SEQRES 12 B 227 ASN ALA LYS LEU LYS PRO VAL TYR ASP SER LEU ASP ALA
SEQRES 13 B 227 VAL ARG ARG ALA ALA LEU ILE ASN MET VAL PHE GLN MET
SEQRES 14 B 227 GLY GLU THR GLY VAL ALA GLY PHE THR ASN SER LEU ARG
SEQRES 15 B 227 MET LEU GLN GLN LYS ARG TRP ASP GLU ALA ALA VAL ASN
SEQRES 16 B 227 LEU ALA LYS SER ARG TRP TYR ASN GLN THR PRO ASN ARG
SEQRES 17 B 227 ALA LYS ARG VAL ILE THR THR PHE ARG THR GLY THR TRP
SEQRES 18 B 227 ASP ALA TYR ALA ASN LEU
HET EYC A1301 30
HET EYC B1301 30
HETNAM EYC 2,2'-ETHYNE-1,2-DIYLBIS{5-[(CHLOROACETYL)
HETNAM 2 EYC AMINO]BENZENESULFONIC ACID}
FORMUL 3 EYC 2(C18 H14 CL2 N2 O8 S2)
FORMUL 5 HOH *64(H2 O)
HELIX 1 AA1 ASN A 2 GLY A 12 1 11
HELIX 2 AA2 GLN A 1220 HIS A 1229 1 10
HELIX 3 AA3 ASN A 1234 ASP A 1248 1 15
HELIX 4 AA4 GLN A 1251 GLY A 51 1 30
HELIX 5 AA5 THR A 59 ASN A 81 1 23
HELIX 6 AA6 LEU A 84 LEU A 91 1 8
HELIX 7 AA7 ASP A 92 ALA A 112 1 21
HELIX 8 AA8 PHE A 114 GLN A 123 1 10
HELIX 9 AA9 ARG A 125 LYS A 135 1 11
HELIX 10 AB1 SER A 136 THR A 142 1 7
HELIX 11 AB2 THR A 142 GLY A 156 1 15
HELIX 12 AB3 TRP A 158 ALA A 162 5 5
HELIX 13 AB4 ASN B 2 GLU B 11 1 10
HELIX 14 AB5 GLN B 1220 LEU B 1228 1 9
HELIX 15 AB6 ASN B 1234 ASP B 1248 1 15
HELIX 16 AB7 GLN B 1251 GLY B 51 1 30
HELIX 17 AB8 THR B 59 ASN B 81 1 23
HELIX 18 AB9 LEU B 84 LEU B 91 1 8
HELIX 19 AC1 ASP B 92 ALA B 112 1 21
HELIX 20 AC2 PHE B 114 GLN B 123 1 10
HELIX 21 AC3 ARG B 125 LYS B 135 1 11
HELIX 22 AC4 SER B 136 THR B 142 1 7
HELIX 23 AC5 THR B 142 GLY B 156 1 15
HELIX 24 AC6 TRP B 158 ALA B 162 5 5
SHEET 1 AA1 3 ARG A 14 LYS A 19 0
SHEET 2 AA1 3 TYR A 25 GLY A 28 -1 O THR A 26 N TYR A 18
SHEET 3 AA1 3 HIS A 31 LEU A 32 -1 O HIS A 31 N ILE A 27
SHEET 1 AA2 3 ARG B 14 LYS B 19 0
SHEET 2 AA2 3 TYR B 25 GLY B 28 -1 O THR B 26 N TYR B 18
SHEET 3 AA2 3 HIS B 31 LEU B 32 -1 O HIS B 31 N ILE B 27
CISPEP 1 ASN A 163 LEU A 164 0 -1.33
CISPEP 2 ASN B 163 LEU B 164 0 -2.94
SITE 1 AC1 10 CYS A 40 GLN A1237 CYS A1258 ALA A1262
SITE 2 AC1 10 ALA A1265 GLN A1266 HOH A1424 SER B 44
SITE 3 AC1 10 GLN B1266 EYC B1301
SITE 1 AC2 9 SER A 44 EYC A1301 CYS B 40 GLN B1237
SITE 2 AC2 9 CYS B1258 ALA B1265 GLN B1266 HOH B1406
SITE 3 AC2 9 HOH B1422
CRYST1 89.522 149.850 55.836 90.00 122.69 90.00 C 1 2 1 8
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.011170 0.000000 0.007170 0.00000
SCALE2 0.000000 0.006673 0.000000 0.00000
SCALE3 0.000000 0.000000 0.021281 0.00000